Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Independent Wellness vs The Edit

Independent Wellness
Site position #170

Lower grade

The Edit
Site position #118

Higher grade

The verdict

The Edit takes it — 70.4/100 to 68.2/100.

The Edit grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The Edit holds one price at every dose, charges nothing to start, refunds in full if you are not approved, and then says none of its published policies actually govern.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueIndependent Wellness +4
54
50
Dose & formulationEven
72
72
Clinical oversightIndependent Wellness +2
82
80
Labs & monitoringIndependent Wellness +3
65
62
FulfillmentThe Edit +14
81
95
Contract termsThe Edit +30
55
85
Independent Wellness · top barThe Edit · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricIndependent WellnessThe Edit
WeighScore68.2/10070.4/100
GradeCC
Site position#170#118
Semaglutide$249/mo (all doses, compounded)$259/mo (standing rate, flat at every dose; $200 covers the first month only)
Tirzepatide$379/mo (all doses, compounded)$349/mo (standing rate, flat at every dose; $300 covers the first month only)
CoverageAll 50 statesAll 50 states (claimed; hedged in the same paragraph, no list published)
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Independent Wellness

Site position #170 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
The Edit

Site position #118 · C

Strengths

  • The price is flat at every dose with no titration ladder, so the figure a reader sees is the figure at maintenance
  • Nothing is charged and no card is taken to begin, and a full refund applies if a clinician does not approve treatment
  • Names its medical director with an NPI number and the medical practice behind him, and names a dispensing pharmacy
  • Prescription medication, injection supplies, the clinician visit and ongoing care are itemized as included, with no membership fee
  • A separate hormone menu is priced beside the GLP-1 lines

Where it loses points

  • $200 and $300 are first-order promotional prices printed larger than the struck standing rates of $259 and $349, and the promotion carries no end date and no code
  • The published cancellation and refund policies say the Membership Agreement controls where they differ, and that nothing on the public site is binding — so the terms a reader can read are not the terms that apply
  • Two-day shipping is transit time only; the site's own shipping policy states an average of 4 to 12 business days from prescription
  • “Available in all 50 U.S. states” is hedged in the same paragraph and no state list is published anywhere
  • The three- and six-month figures are one charge, not a monthly rate, and the per-month numbers beside them are arithmetic rather than billing
  • The named pharmacy is described as one member of a plural pharmacy network whose other members are not named
  • No compounding class is stated, and whether a separate visit fee is ever charged is not answered

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard